- Home
- AEIS vs QGEN Comparison
AEIS vs QGEN Comparison
Compare AEIS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AEIS | QGEN |
|---|---|---|
| Founded | 1981 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 10.2B |
| IPO Year | 1996 | 1998 |
Fundamental Metrics
Financial Performance| Metric | AEIS | QGEN |
|---|---|---|
| Price | $301.99 | $36.80 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $307.73 | $45.76 |
| AVG Volume (30 Days) | 919.2K | ★ 2.0M |
| Earning Date | 05-04-2026 | 05-06-2026 |
| Dividend Yield | 0.11% | ★ 7.17% |
| EPS Growth | ★ 168.53 | N/A |
| EPS | ★ 1.58 | N/A |
| Revenue | ★ $453,095,000.00 | N/A |
| Revenue This Year | $22.53 | $8.18 |
| Revenue Next Year | $13.38 | $5.71 |
| P/E Ratio | $200.87 | ★ $24.01 |
| Revenue Growth | ★ 38.39 | N/A |
| 52 Week Low | $112.72 | $32.53 |
| 52 Week High | $397.44 | $57.82 |
Technical Indicators
Market Signals| Indicator | AEIS | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 37.31 | 56.56 |
| Support Level | $292.32 | $32.85 |
| Resistance Level | $355.00 | $48.53 |
| Average True Range (ATR) | 16.72 | 0.80 |
| MACD | -2.51 | 0.64 |
| Stochastic Oscillator | 17.14 | 94.23 |
Price Performance
Historical ComparisonAbout AEIS Advanced Energy Industries Inc.
Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).